c-Myc mRNAs have been designed to produce high expression level of c-Myc protein. OZ Biosciences mRNAs are produced by in vitro transcription. mRNAs are stabilised at the 5' end by modified nucleotides capping (Cap1) and contain a poly(A) tail at the 3' end. Sequences have been optimised to yield improved stability and performance.

• Ready-to-use stabilised c-Myc mRNA
• Concentration: 1.0mg/mL in 1mM sodium citrate, pH 6.4
• Length: 1584nt
• Molecular weights: MRNA58: 512800g/mol; MRNA59: 518800g/mol; MRNA60: 515800g/mol
• MRNA58 does not bear any additional nucleotide modifications
• MRNA59 is modified with 5-methoxyuridine (5moU) to reduce innate immune responses
• MRNA60 is modified with N1-methyl-pseudouridine to reduce innate immune response